Related Experiment Video
Updated: May 1, 2026

Methyl-binding DNA capture Sequencing for Patient Tissues
Published on: October 31, 2016
Frequent MYC coamplification and DNA hypomethylation of multiple genes on 8q in 8p11-p12-amplified breast carcinomas
T Z Parris1, A Kovács2, S Hajizadeh2
1Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Cancer Center, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
Abstract:
Genetic and epigenetic (DNA methylation, histone modifications, microRNA expression) crosstalk promotes inactivation of tumor suppressor genes or activation of oncogenes by gene loss/hypermethylation or duplications/hypomethylation, respectively. The 8p11-p12 chromosomal region is a hotspot for genomic aberrations (chromosomal rearrangements, amplifications and deletions) in several cancer forms, including breast carcinoma where amplification has been associated with increased proliferation rates and reduced patient survival. Here, an integrative genomics screen (DNA copy number, transcriptional and DNA methylation profiling) performed in 229 primary invasive breast carcinomas identified substantial coamplification of the 8p11-p12 genomic region and the MYC oncogene (8q24.21), as well as aberrant methylation and transcriptional patterns for several genes spanning the 8q12.1-q24.22 genomic region (ENPP2, FABP5, IMPAD1, NDRG1, PLEKHF2, RRM2B, SQLE, TAF2, TATDN1, TRPS1, VPS13B). Taken together, our findings suggest that MYC activity and aberrant DNA methylation may also have a pivotal role in the aggressive tumor phenotype frequently observed in breast carcinomas harboring 8p11-p12 regional amplification.
Insights
Genomic alterations in the 8p11-p12 region and MYC oncogene coamplification are common in breast cancer. Aberrant DNA methylation also contributes to aggressive tumor phenotypes in these patients.
Area of Science:
- Genomics
- Cancer Biology
- Epigenetics
Background:
- Genetic and epigenetic crosstalk influences oncogene and tumor suppressor gene activity.
- The 8p11-p12 chromosomal region is frequently altered in cancers, particularly breast carcinoma, where amplification correlates with poor prognosis.
Purpose of the Study:
- To investigate the genomic and epigenomic landscape of the 8p11-p12 region in breast carcinoma.
- To identify potential drivers of aggressive tumor phenotypes associated with 8p11-p12 amplification.
Main Methods:
- Integrative genomics screen including DNA copy number, transcriptional, and DNA methylation profiling.
- Analysis of 229 primary invasive breast carcinoma samples.
Main Results:
- Identified substantial coamplification of the 8p11-p12 region and the MYC oncogene (8q24.21).
- Detected aberrant methylation and transcriptional patterns for multiple genes within the 8q12.1-q24.22 genomic region.
- Observed a correlation between 8p11-p12 amplification, MYC activity, and aberrant DNA methylation in aggressive breast tumors.
Conclusions:
- MYC oncogene activity and aberrant DNA methylation play crucial roles in the aggressive phenotype of breast carcinomas with 8p11-p12 amplification.
- These findings highlight potential therapeutic targets for managing aggressive breast cancer subtypes.
Related Concept Videos
Abnormal Proliferation
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Induced Pluripotent Stem Cells
Somatic...

